Registry study of immune-related adverse events using electronic patient-reported outcome in patients with cancer receiving immune checkpoint inhibitors: protocol for a multicentre cohort study

INTRODUCTION: The use of immune checkpoint inhibitors (ICIs) is rapidly expanding in cancer treatment. ICIs have a unique safety profile, characterised by immune-related adverse events (irAEs). The safety profile of ICIs lacks patient experience and perspectives. This study primarily aims to obtain...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirata, Taiki, Kawaguchi, Takashi, Azuma, Kanako, Torii, Ayako, Usui, Hiroaki, Kim, Soan, Hayama, Tatsuya, Hirate, Daisuke, Kawahara, Yosuke, Kumihashi, Yuki, Chisaka, Tomomi, Wako, Tetsuya, Yoshimura, Akinobu, Miyaji, Tempei, Yamaguchi, Takuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668225/
https://www.ncbi.nlm.nih.gov/pubmed/37993166
http://dx.doi.org/10.1136/bmjopen-2023-073724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668225/
https://www.ncbi.nlm.nih.gov/pubmed/37993166
http://dx.doi.org/10.1136/bmjopen-2023-073724

Ejemplares similares